We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$5.48B
AUM Growth
+$244M
Cap. Flow
-$178M
Cap. Flow %
-3.24%
Top 10 Hldgs %
8.16%
Holding
4,138
New
948
Increased
818
Reduced
676
Closed
1,018

Sector Composition

Rank Sector Weight
1 Financials 13.14%
2 Industrials 11.82%
3 Healthcare 9.09%
4 Consumer Discretionary 7.46%
5 Technology 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDCE
3751
CALL
DELISTED
PDC Energy, Inc.
PDCE
-1,200
Closed -$69K
ARBGU
3752
DELISTED
Aequi Acquisition Corp Unit
ARBGU
-13,082
Closed -$131K
CPUH.U
3753
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
-32,400
Closed -$319K
TLGA.U
3754
DELISTED
TLG Acquisition One Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TLGA.U
-140,912
Closed -$1.39M
BLNGU
3755
DELISTED
Belong Acquisition Corp. Units
BLNGU
-55,486
Closed -$548K
ISEE
3756
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-10,000
Closed -$179K
USX
3757
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-22,060
Closed -$54K
RXDX
3758
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-5,900
Closed -$348K
RXDX
3759
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-1,627
Closed -$96K
RXDX
3760
PUT
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-1,000
Closed -$59K
STSA
3761
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-93,672
Closed -$562K
ROCGU
3762
DELISTED
Roth CH Acquisition IV Co. Unit
ROCGU
-54,506
Closed -$550K
SI
3763
CALL
DELISTED
Silvergate Capital Corporation
SI
-15,000
Closed -$1.13M
SI
3764
PUT
DELISTED
Silvergate Capital Corporation
SI
-9,600
Closed -$723K
PGRWU
3765
DELISTED
Progress Acquisition Corp. Units
PGRWU
-32,305
Closed -$324K
EVOJU
3766
DELISTED
Evo Acquisition Corp. Unit
EVOJU
-43,427
Closed -$428K
JNCE
3767
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-22,719
Closed -$53K
IPVIU
3768
DELISTED
InterPrivate IV InfraTech Partners Inc. Units
IPVIU
-71,000
Closed -$697K
ALTIW
3769
DELISTED
AlTi Global Inc Warrant
ALTIW
-26,469
Closed -$8K
ML
3770
DELISTED
MoneyLion Inc.
ML
-3,456
Closed -$93K
SJR
3771
DELISTED
Shaw Communications Inc.
SJR
-13,200
Closed -$321K
ATCO
3772
DELISTED
Atlas Corp.
ATCO
-17,615
Closed -$245K
IAA
3773
DELISTED
IAA, Inc. Common Stock
IAA
-150,159
Closed -$4.78M
LYLT
3774
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
-163,275
Closed -$198K
HPX
3775
DELISTED
HPX Corp.
HPX
-82,366
Closed -$817K

Similar funds

Walleye Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Walleye Capital held 4,138 positions worth $5.48B, up 4.6% from $5.24B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Walleye Capital withdrew a net $178M in Q4 2022, closing 1,018 positions and reducing 676 holdings. Its most notable exit was Expand Energy Corp Class B Warrants, an estimated $191M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Walleye Capital opened a new position in State Street SPDR S&P Retail ETF worth $43.9M.

  • Walleye Capital's largest Q4 2022 buy was State Street SPDR S&P Retail ETF: 726,921 shares worth $43.9M.
  • Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $98.3M increase.
  • Walleye Capital's biggest Q4 2022 reduction was Equity Residential, cutting an estimated $20.2M.
  • Walleye Capital fully exited Expand Energy Corp Class B Warrants in Q4 2022, selling an estimated $191M.
  • Walleye Capital's ten largest holdings make up 8.2% of its $5.48B portfolio in Q4 2022.
  • Walleye Capital opened 948 new positions and closed 1,018 in Q4 2022.
  • Walleye Capital's portfolio value rose 4.6% quarter-over-quarter to $5.48B.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.